These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30004597)

  • 1. The clinical effects of l-arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon.
    Curtiss P; Schwager Z; Lo Sicco K; Franks AG
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):497-503. PubMed ID: 30004597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-arginine therapy in Raynaud's phenomenon?
    Agostoni A; Marasini B; Biondi ML; Bassani C; Cazzaniga A; Bottasso B; Cugno M
    Int J Clin Lab Res; 1991; 21(2):202-3. PubMed ID: 1815764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
    Dooley A; Gao B; Bradley N; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
    Rheumatology (Oxford); 2006 Jun; 45(6):676-84. PubMed ID: 16399843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma.
    Freedman RR; Girgis R; Mayes MD
    Lancet; 1999 Aug; 354(9180):739. PubMed ID: 10475187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients.
    Reyhani A; Celik Y; Karadag H; Gunduz O; Asil T; Sut N
    Neurol Sci; 2017 Jul; 38(7):1287-1291. PubMed ID: 28455769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral L-arginine can reverse digital necrosis in Raynaud's phenomenon.
    Rembold CM; Ayers CR
    Mol Cell Biochem; 2003 Feb; 244(1-2):139-41. PubMed ID: 12701823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
    J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between systemic sclerosis, arginine and asymmetric dimethylarginine.
    Zhang L; Wan YN; Zhao JH; Wang YJ; Wang YX; Yan JW; Huang XL; Wang J
    Inflammation; 2015 Feb; 38(1):218-23. PubMed ID: 25252854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: implications for vascular dysfunction and progression of disease.
    Rajagopalan S; Pfenninger D; Kehrer C; Chakrabarti A; Somers E; Pavlic R; Mukherjee D; Brook R; D'Alecy LG; Kaplan MJ
    Arthritis Rheum; 2003 Jul; 48(7):1992-2000. PubMed ID: 12847693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis.
    Blaise S; Maas R; Trocme C; Kom GD; Roustit M; Carpentier PH; Cracowski JL
    J Rheumatol; 2009 May; 36(5):984-8. PubMed ID: 19332631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
    Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
    Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects.
    Pereira EC; Bertolami MC; Faludi AA; Salem M; Bersch D; Abdalla DS
    Free Radic Res; 2003 May; 37(5):529-36. PubMed ID: 12797474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.
    Laleman W; Omasta A; Van de Casteele M; Zeegers M; Vander Elst I; Van Landeghem L; Severi T; van Pelt J; Roskams T; Fevery J; Nevens F
    Hepatology; 2005 Dec; 42(6):1382-90. PubMed ID: 16317694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
    Toutouzas K; Riga M; Stefanadi E; Stefanadis C
    Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.